Anti‐IL‐5 mAb (mepolizumab) vs placebo (on top of topical steroids)Generic quality of life measures · patients with severe chronic rhinosinusitis with nasal polyps1 finding from 1 reviewBiologics for chronic rhinosinusitis 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 105 participantsLow
Anti‐IL‐5 mAb (mepolizumab) vs placebo (on top of topical steroids)Disease‐specific quality of life · patients with severe chronic rhinosinusitis with nasal polyps1 finding from 1 reviewBiologics for chronic rhinosinusitis 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 105 participantsLow